Results of the Valiant Mona LSA early feasibility study for descending thoracic aneurysms

The Valiant Mona LSA system demonstrates technical and treatment success, relative safety, and early durability in its initial use in DTA patients. Midterm results are expected as patients are monitored at regular intervals to 5 years.